We are focused on developing and marketing branded and generic formulations. Our formulations business spans across various geographies primarily the US, India, Europe, Latin America and Rest of the World. We focus on manufacturing niche products across therapeutic areas of dermatology, respiratory and oncology. We have 11 manufacturing facilities across India, the US, Argentina and Czech Republic. These facilities are approved by various regulatory bodies, including the U.S. FDA, MHRA UK and ANVISA Brazil. Being a research-driven organization, we have also invested in dedicated R&D centers for global markets.